Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

R-salbutamol sulphate

EU orphan designation number: EU/3/07/481   
Active ingredient: R-salbutamol sulphate
Indication: Treatment of cutaneous forms of lupus erythematosus
Sponsor: Astion Pharma A/S
Fruebjergvej 3, 2100 København O, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Orphan designation EMEA/OD/032/07 (2007)4338 of 14/09/2007